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Abstract
Severe maternal morbidity and mortality have been rising in the United States. To begin a national 
effort to reduce morbidity, a specific call to identify all pregnant and postpartum women 
experiencing admission to an intensive care unit or receipt of 4 or more units of blood for routine 
review has been made. While advocating for review of these cases, no specific guidance for the 
review process was provided. Therefore, the aim of this expert opinion is to present guidelines for 
a standardized severe maternal morbidity interdisciplinary review process to identify systems, 
professional, and facility factors that can be ameliorated, with the overall goal of improving 
institutional obstetric safety and reducing severe morbidity and mortality among pregnant and 
recently pregnant women. This opinion was developed by a multidisciplinary working group that 
included general obstetrician–gynecologists, maternal–fetal medicine subspecialists, certified 
nurse–midwives, and registered nurses all with experience in maternal mortality reviews. A 
process for standardized review of severe maternal morbidity addressing committee organization, 
review process, medical record abstraction and assessment, review culture, data management, 
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review timing, and review confidentiality is presented. Reference is made to a sample severe 
maternal morbidity abstraction and assessment form.
To begin a national effort to reduce maternal morbidity, a specific call to identify all 
pregnant and postpartum women experiencing admission to an intensive care unit or receipt 
of 4 or more units of blood for routine review has been made.1 The increasing rates of 
maternal mortality and severe morbidity in the United States have been well-documented in 
recent publications.2–5 It is therefore appropriate that efforts should be focused on reducing 
maternal severe morbidity and death.6–8 Reviews of maternal deaths in order to identify 
likely preventable deaths and interventions to reduce preventable deaths have been 
widespread for years.9,10 However, the call to similarly implement routine standardized 
identification and evaluation of severe maternal morbidity cases by every birthing facility in 
the United States has only recently been highlighted.1
Although several methods have been proposed to identify women with severe maternal 
morbidity, the criteria proposed by Callaghan et al were admission of the mother to an 
intensive care unit (ICU) or receipt of 4 or more units of blood.1,11 These criteria were 
chosen because they are simple and have high sensitivity and specificity for identifying 
pregnant and recently postpartum women with severe morbidity.12,13 The sensitivities were 
63% to 86% when each was used individually, but up to 100% if combined.12,13 It should be 
emphasized that while these criteria are reliable markers of potential severe maternal 
morbidity, the fact that a patient was admitted to an ICU or received 4 or more units of 
blood alone do not imply that care and systems were substandard. In fact, it is the review of 
the case that ultimately determines 1) if the case is a severe maternal morbidity and 2) 
whether there were improvements in processes or care necessary. While advocating for 
review of these cases, no specific guidance for the review process were provided.1
The aim of this document is to present a suggested standardized severe maternal morbidity 
review process to identify systems, professional, and facility factors that could be 
ameliorated, with the overall goal of improving institutional obstetric safety and reducing 
severe morbidity and mortality among pregnant and recently pregnant women. This opinion 
was developed by a multidisciplinary working group that included general obstetrician–
gynecologists, maternal–fetal medicine subspecialists, certified nurse–midwives, and 
registered nurses. These individuals were appointed by their respective organizations, 
including the American College of Obstetricians and Gynecologists (ACOG), Society for 
Maternal-Fetal Medicine, Association of Women’s Health, Obstetric and Neonatal Nurses 
(AWHONN), American College of Nurse-Midwives, and Centers for Disease Control and 
Prevention, and all authors have state or national experience with maternal mortality review. 
The review process, organization, and forms were modeled after Illinois and California 
maternal mortality review processes and forms9 (personal communication, Elizabeth 
Lawton, CA Department of Public Health, Maternal Child and Adolescent Health Division, 
and Elliot Main, Department of Obstetrics and Gynecology, California Pacific Hospital; 
2013).
The following recommendations for the development and maintenance of a severe maternal 
morbidity review process are intended as guidelines and could be modified at individual 
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centers. This process is consistent with The Joint Commission’s template for root cause 
analysis to be employed for sentinel events.14 Of note, maternal deaths are considered 
sentinel events and thus reviewed by root cause analysis. We suggest that the morbidity 
review process herein described could be modified and used for maternal death review if 
appropriate for local process.
1. Severe Maternal Morbidity Review Committee Organization
a. Hospital or birth facility leadership appoints a standing Severe Maternal Morbidity 
Committee. This may require new bylaws.
b. Committee membership is multidisciplinary and reflects the professional make-up 
of clinicians and staff who provide or support maternity services institutionally. 
Example members are: obstetricians, family physicians, certified nurse–midwives, 
and advanced-practice nurses; anesthesia personnel; registered nurses providing 
antepartum, intrapartum, or postpartum care; and members of the hospital Quality 
Improvement team and administration. A public member or patient advocate could 
be considered. Ad-hoc members representing other expertise can be invited as 
deemed necessary. If there are learners such as residents or fellows, they should be 
represented as well.
c. The Committee has a chairperson, an individual responsible for minutes, and an 
individual responsible for data management.
2. Severe Maternal Morbidity Review Process
a. At a minimum, the Committee will review all pregnant or postpartum women 
receiving 4 or more units of blood or admitted to an ICU. These criteria may be 
expanded as needed by an individual center.
b. For each case of severe maternal morbidity, a debriefing with involved care 
providers, which does not replace the standardized review, is suggested and ideally 
occurs proximate to the severe maternal morbidity. Information obtained from the 
debriefing can be retained for the standardized review process. There are several 
debrief tools available (https://www.cmqcc.org/resources/1533/download and 
http://www.med.unc.edu/ticker/toolkit/teamwork/brief-debrief-form). Another 
example is a debrief tool developed by C. Lee and D. Goffman, who gave 
permission for its inclusion in this article (Montefiore Medical Center/Albert 
Einstein College of Medicine, Bronx, NY) (Fig. 1).
c. The severe maternal morbidity review should be conducted at each facility, if 
possible.
d. Centers with a low volume of deliveries or obstetric providers may opt to partner 
with centers within their perinatal region, or outsource their reviews to a center 
with sufficient staff and providers to conduct the reviews.
e. Leaders from regional perinatal centers, state maternal and child health 
departments, state medical and nursing societies, and ACOG districts could identify 
experts who will be available to assist local committees.
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f. Chart abstraction for patients whose care is being reviewed will be done by an 
individual trained in the abstraction and review process.
g. Data abstraction and review should follow a specific format to facilitate consistent 
collection of meaningful information that can be adequately evaluated. One method 
of achieving this is to use a specific form for data abstraction and review. A good 
example of such a form is the Severe Maternal Morbidity Abstraction and 
Assessment Form (www.safehealthcareforeverywoman.org). This form is 
consistent with the root cause analysis and action framework as it applies to 
obstetric sentinel events.14 Other tools such as the fishbone diagram for root cause 
analysis or sentinel event could also be used. The goals of the abstraction are to 
capture specific data as well as the essence of the severe morbidity, including a 
narrative with a detailed time line of the pertinent events. To aid the abstractor in 
identifying key issues, a sample list of disease-specific questions associated with 
severe maternal morbidity are included (Appendix). These types of questions can 
be used for any morbidity and are meant only as a guide.
h. The abstracted data should be presented to the Severe Maternal Morbidity Review 
Committee for their review and assessment.
i. The assessment portion of the Severe Maternal Morbidity Abstraction and 
Assessment Form is completed based on the results of the Committee’s review of 
the case. Each review should conclude with an assessment of whether there were 
opportunities to improve outcome. If identified, these opportunities are enumerated, 
and specific recommendations for potential alterations in outcome should be 
suggested to the appropriate responsible institutional person or department.
j. Each institution should have agreed-upon mechanisms in place to implement any 
recommendations and to evaluate the effects of the suggested changes.
3. Severe Maternal Morbidity Review Culture
Reviews are not conducted as peer review, which addresses credentialing and formal 
discipline issues, but rather as expert review focused broadly on improving systems and 
care provision. If a case has peer-review issues, then these should have been identified 
and handled in the existing institutional peer-review process. Expert review may be 
anonymous and has no authority to discipline individuals, but rather looks for 
opportunities to reduce preventable morbidity and mortality. State laws often protect 
expert review from discovery, but this must be determined on a state-by-state basis. The 
culture and tone of the review process must be nonjudgmental, and the final assessment, 
with respect to potential improvements in care, rendered as dispassionately as possible. 
One example of such an approach is the “Just Culture,” whose key principles include 
educating caregivers about risk, holding them responsible for following best practices, 
creating a safe haven around reporting, and recognizing what can and cannot be 
controlled.15
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a. Data, including outcome data, are trended. The identification of potentially 
improvable measures as the primary goal of these reviews is to recognize systems, 
provider, and patient factors that are amenable to alterations that could improve 
outcomes in future cases. Using a consistent data form, such as the Severe Maternal 
Abstraction and Assessment Form, will facilitate acquisition of analyzable data.
b. Each facility will determine the best method to disseminate important 
recommendations for improvement in outcomes locally and more broadly.
c. Data from internal facility reviews could be aggregated at regional levels (ie, 
perinatal regional, state, and ACOG districts, and AWHONN sections and 
chapters). De-identified aggregate data reviewed at regional and national levels 
could help to identify trends and, more importantly, opportunities for improvement 
in the delivery of obstetric health care. ACOG districts may accumulate reports and 
share trend and action data with others.
d. Consideration could be given to utilizing Patient Safety Organizations in this 
national effort to consolidate and disseminate appropriate findings. Patient Safety 
Organizations were developed by the Patient Safety Improvement Act of 2005 
(www.pso.ahrq.gov) and provide privilege and confidentiality to clinicians and 
health care organizations to collect and analyze data to improve quality by reducing 
risks associated with patient care.
5. Review Timing
Depending on the severity of the event, reviews should occur soon after the event and 
include obtaining information from the debriefing. The more severe the event, the more 
proximate the review should be to the event. Hospitals that wish to review a broader list 
of morbidities or that have a large number of cases may choose to have the Severe 
Maternal Morbidity Review Committee meet regularly.
6. Confidentiality and Protection from Discovery
a. The Severe Maternal Morbidity Review Committee should be sanctioned by the 
hospital and protected from discovery. State codes and relevant statutes must be 
reviewed to determine if protection or authority exists for maternal morbidity 
review. State ACOG sections and hospital associations may be helpful in 
identifying statutes and lobbying state legislative bodies for appropriate changes if 
needed.
b. All Committee members sign affidavits of confidentially.
CONCLUSIONS
Severe maternal morbidity in the United States has significantly increased since the late 
1990s, affecting at least 50,000 women per year.3 Without efforts to systematically identify 
and evaluate cases of severe maternal morbidity in a multidisciplinary format, effective and 
sustained morbidity reduction would seem unlikely. We conclude that every U.S. birthing 
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facility should implement a standardized review process for cases of severe maternal 
morbidity in order to identify system and caregiver improvement opportunities that may 
prevent future instances of serious maternal morbidity and mortality. Our recommendations 
are intended to be guidelines for review, and the Severe Maternal Morbidity Abstraction and 
Assessment Form is one example of a format to review severe maternal morbidity. Because 
of the proven high sensitivity and specificity for severe maternal morbidity and the relative 
ease of use, we strongly recommend utilizing the criteria of ICU admission or receipt of 4 or 
more units of blood to identify women with severe maternal morbidity.1,11–13 These criteria 
may be modified or expanded as needed by an individual center. It should be emphasized 
that these criteria, in and of themselves, do not convey a judgment about the care of the 
patient. Only review of the case can provide such insight. Therefore, neither ICU admission 
nor transfusion of 4 or more units of blood should be used as quality measures.
Individual facility review and assessment, with implementation of recommendations, are 
expected to improve local care. However, also important is the potential to aggregate de-
identified data at regional and national levels to allow sufficient numbers for statistical 
analysis, which may lead to significant systems improvement in care for all pregnant and 
postpartum women.
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Appendix: Sample Disease-Specific Questions to Guide Abstraction
Hemorrhage
1. Was the hemorrhage recognized in a timely fashion?
2. Were signs of hypovolemia recognized in a timely fashion?
3. Were transfusions administered in a timely fashion?
4. Were appropriate interventions (eg, medications, balloons, sutures) used?
5. Were modifiable risk factors (eg, oxytocin, induction, chorioamnionitis, delay in 
delivery) managed appropriately?
6. Was sufficient assistance (eg, additional doctors, nurses, or others) requested and 
received?
Hypertensive disease
1. Was hypertension recognized appropriately?
2. Did the woman appropriately receive magnesium sulfate?
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3. Was severe hypertension treated in a timely fashion?
4. Was the woman delivered at the appropriate time relative to her hypertensive 
disease?
5. Were any complications related to hypertensive disease managed appropriately?
Infectious disease, sepsis
1. Was the diagnosis of sepsis or infectious disease made in a timely fashion?
2. Were appropriate antibiotics used after diagnosis? How long to treatment?
3. Did the woman receive appropriate volume of intravenous fluids?
4. Were significant modifiable risk factors for infectious complications identified?
Other diseases as necessary
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Sample debrief tool for maternal severe morbidity or death—Montefiore Medical Center. 
Figure courtesy of C. Lee and D. Goffman. Used with permission.
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